Hjalmar Lagast
Overview
Explore the profile of Hjalmar Lagast including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murrell D, Paller A, Bodemer C, Browning J, Nikolic M, Barth J, et al.
Orphanet J Rare Dis
. 2020 Jul;
15(1):190.
PMID: 32693833
Background: Chronic wounds are a fundamental issue for patients with epidermolysis bullosa (EB). Herein, we assess the natural history of wound closure in patients with EB who were randomly assigned...
2.
Paller A, Browning J, Nikolic M, Bodemer C, Murrell D, Lenon W, et al.
Orphanet J Rare Dis
. 2020 Jun;
15(1):158.
PMID: 32576219
Background: Epidermolysis bullosa (EB) is a rare genetic disorder that manifests as blistering and/or skin erosion. There is no approved treatment for EB; current standard of care consists of wound...
3.
Bruckner A, Losow M, Wisk J, Patel N, Reha A, Lagast H, et al.
Orphanet J Rare Dis
. 2020 Jan;
15(1):1.
PMID: 31900176
Background: Little information is available regarding the burden of living with and managing epidermolysis bullosa, including the distinct challenges faced by patients with different disease types/subtypes. Methods: A 90-question/item survey...
4.
Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study
Narita I, Ohashi T, Sakai N, Hamazaki T, Skuban N, Castelli J, et al.
Clin Exp Nephrol
. 2020 Jan;
24(2):157-166.
PMID: 31889231
Background: Fabry disease is a progressive X-linked lysosomal disorder. In this subgroup analysis of the global phase III ATTRACT study, the efficacy and safety of oral migalastat, a pharmacologic chaperone,...
5.
Clarke B, Vokes T, Bilezikian J, Shoback D, Lagast H, Mannstadt M
Endocrine
. 2016 Oct;
55(1):273-282.
PMID: 27734257
In hypoparathyroidism, inappropriately low levels of parathyroid hormone lead to unbalanced mineral homeostasis. The objective of this study was to determine the effect of recombinant human parathyroid hormone, rhPTH(1-84), on...
6.
Lakatos P, Bajnok L, Lagast H, Valkusz Z
Endocr Pract
. 2015 Dec;
22(5):523-32.
PMID: 26684150
Objective: Hypoparathyroidism is characterized by inadequate parathyroid hormone (PTH), resulting in hypocalcemia, hyperphosphatemia, and bone abnormalities. Adults with hypoparathyroidism treated with recombinant human PTH, rhPTH(1-84), in the 24-week, phase III...
7.
Clarke B, Berg J, Fox J, Cyran J, Lagast H
Clin Ther
. 2014 May;
36(5):722-36.
PMID: 24802860
Background: Impaired mineral homeostasis affecting calcium, phosphate, and magnesium is a result of parathyroid hormone (PTH) deficiency in hypoparathyroidism. The current standard of treatment with active vitamin D and oral...
8.
Mannstadt M, Clarke B, Vokes T, Brandi M, Ranganath L, Fraser W, et al.
Lancet Diabetes Endocrinol
. 2014 Mar;
1(4):275-83.
PMID: 24622413
Background: Hypoparathyroidism results in impaired mineral homoeostasis, including hypocalcaemia and hyperphosphataemia. Treatment with high-dose oral calcium and active vitamin D does not provide adequate or consistent control of biochemical indices...
9.
Hadker N, Egan J, Sanders J, Lagast H, Clarke B
Endocr Pract
. 2014 Jan;
20(7):671-9.
PMID: 24449664
Objective: Hypoparathyroidism is a rare disease caused by lack of parathyroid hormone (PTH) leading to hypocalcemia, hyperphosphatemia, and a variety of symptoms. This study aimed to quantify the clinical and...
10.
Powers J, Joy K, Ruscio A, Lagast H
J Bone Miner Res
. 2013 Jun;
28(12):2570-6.
PMID: 23737456
Hypoparathyroidism is a rare endocrine disorder whose incidence and prevalence have not been well defined. This study aimed to 1) estimate the number of insured adult patients with hypoparathyroidism in...